Regulus Therap (RGLS) Reports Q3 Loss of $15.98

Regulus Therap (NASDAQ: RGLS) reported Q3 EPS of ($15.98), versus ($11.68) reported last year. Revenue for the quarter came in at $2.8 million, versus $3.81 million reported last year.

For earnings history and earnings-related data on Regulus Therap (RGLS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Can global equities keep rising? UBS sees these factors driving upside
• Arrive AI and DXC Technology partner to bring delivery tech to factories